Rajabally, Yusuf A and Fatehi, Farzad (2019). Outcome measures for chronic inflammatory demyelinating polyneuropathy in research:relevance and applicability to clinical practice. Neurodegenerative disease management, 9 (5), pp. 259-266.
Abstract
Outcome measures are recommended in the management of chronic inflammatory demyelinating polyneuropathy (CIDP). Various scales have been proposed in recent years, some now commonly utilized in daily clinical practice. The available evidence base relies itself on randomized controlled trial data obtained over the past 30 years, with several studies using different primary and secondary outcomes. We here review the different outcome measures used in CIDP research in relation to those currently recommended for clinical management. We consider the evidence base for CIDP treatment from the primary and secondary outcomes used in these studies and attempt to assess how this may relate to current clinical practice of routine evaluation of treatment effects and long-term monitoring.
Publication DOI: | https://doi.org/10.2217/nmt-2019-0009 |
---|---|
Divisions: | College of Health & Life Sciences |
Additional Information: | For full bibliographic citation, please refer to the version available at www.futuremedicine.com; https://www.futuremedicine.com/doi/abs/10.2217/nmt-2019-0009?journalCode=nmt |
Uncontrolled Keywords: | chronic inflammatory demyelinating polyneuropathy,clinical practice,outcome measures |
Publication ISSN: | 1758-2032 |
Last Modified: | 04 Dec 2024 08:16 |
Date Deposited: | 17 Sep 2021 12:12 |
Full Text Link: | |
Related URLs: |
https://www.fut ... 7/nmt-2019-0009
(Publisher URL) |
PURE Output Type: | Review article |
Published Date: | 2019-10-03 |
Accepted Date: | 2019-08-08 |
Authors: |
Rajabally, Yusuf A
Fatehi, Farzad |